The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Tag Archives: Supreme Court

Key Quotes from the U.S. Supreme Court’s Decision in Bilski Shows No Current Impact on Biotech

Many expected the U.S. Supreme Court’s decision in Bilski to have a far-reaching impact on methods patents, including biotechnology diagnostics and drug development. That turned out not to be the case, with the Court deciding on narrow grounds that the actual patent at issue was improperly granted and reminding the Federal Circuit that it prefers [...]

Supreme Court Hears Oral Arguments in False Claims Act Whistleblower Case

The United States Supreme Court heard oral arguments today in a case we noted in June in which amici curiae PhRMA and BIO urged the Supreme Court to limit whistleblower suits under the False Claims Act (FCA). Feel like you were really there by reading the full transcript of the oral argument (pdf). Out loud. In [...]

A Big Week for Confirmations: Sotomayor, Collins, Kappos Movin’ on Up

Today saw three significant confirmations by the U.S. Senate of interest to the biotech community: Sonia Sotomayor’s nomination to the U.S. Supreme Court was confirmed 68-31; Francis Collins was confirmed as the next director of the National Institutes of Health; and David Kappos, ex of IBM, will be the new director of the U.S. Patent and Trademark Office. We [...]

Preemption Update: Waxman and Pallone Hit the Ground Running

When we reported on the Supreme Court’s decision in Wyeth v. Levine, we wondered what the effect would be on legislation proposed by Reps. Waxman and Pallone.  We did not have to wonder long — they introduced legislation yesterday, with a parallel effort from Sens. Kennedy and Leahy, to moot the Supreme Court’s decision in Reigel v. [...]

Follow

Get every new post delivered to your Inbox.

Join 93 other followers